资讯
Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...
Details of the new rules for COVID-19 vaccine approvals were also outlined in an article published by The New England Journal ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
The rollout of updated Covid vaccines for healthy children and adults this fall is likely to be delayed after the FDA said it ...
Top officials for the FDA laid out new requirements limiting access to yearly COVID shots for healthy younger adults and ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.
The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果